🗳️ Ohio Referendum Freeze, 280E Credit Loss, And The Hemp Rulebook Gap

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition tracks a referendum sprint in Ohio that could suspend a legislative rewrite of adult use rules and drag intoxicating hemp into the same ballot fight. We also cover a federal court ruling that narrows ERC relief under 280E, and the growing policy drift that keeps CBD markets operating under permanent uncertainty. A new episode of The Hybrid is out today, and we get into ballot question repeals in Massachusetts and Maine with the kind of clarity that only comes from watching these fights up close. (Note: we recorded this the day before Maine failed to make the ballot…)

Today’s edition is supported by The Rundown AI and I Hate It Here. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.

🗳️ Ballot rewrites and backstops
💸 280E risk gets sharper
🥤 Hemp lanes keep colliding

Count the votes. Read the fine print.

📌 What Happened: Ohio’s citizen referendum campaign to block Senate Bill 56 cleared its first procedural hurdle after the Attorney General certified revised petition language and the Secretary of State verified initial signatures. Organizers now face a compressed sprint to submit roughly 248,000 valid signatures by March 19th, the day before the law is scheduled to take effect, and they also have to hit county distribution thresholds across the state. The new law, signed by Gov. DeWine, materially reshapes the adult use framework voters approved in 2023 by locking in a 400 dispensary cap, tightening ownership limits, stripping out designated social equity license allocations, and adding new criminal penalties tied to possession and handling. The bill also folds intoxicating hemp restrictions into the same package and sets a strict THC threshold that pushes most intoxicating hemp products out of general retail. If sufficient signatures are certified on time, the law is suspended and the question goes to voters in November. If the effort fails, the rewrite becomes the operative framework on March 20th.

💡 Why It Matters: This is about durable consent and who holds authority after election night. Voters approved a market structure, and lawmakers responded by narrowing it and removing protections that many consumers and small businesses assumed were part of the bargain. Referendum mechanics turn that tension into a direct governance test: does the initiative process produce settled policy, or a first draft that can be rewritten in the next session. The timeline alone creates planning drag, since capital, real estate, and hiring decisions slow when the rules may change twice in the span of a year. The hemp overlay raises the temperature because it merges two consumer lanes with different risk narratives and different coalitions, then dares everyone to pick a single side. Ohio is also sitting on a real precedent, since voters have used referendums before to overturn major legislative moves, and the political class remembers how that feels.

💸 Court Blocks Covid Payroll Credit For Cannabis Under 280E

The U.S. Court of Federal Claims ruled a cannabis dispensary cannot claim the refundable portion of the Employee Retention Credit because 280E bars credits for businesses trafficking in Schedule I or II substances. The taxpayer tried to treat the refundable portion as a wage subsidy rather than a credit, and the court rejected that move. This ruling tightens the perimeter around a pandemic-era strategy many advisors pitched as low-risk, and it gives auditors a clean citation when they come knocking. It also reinforces a blunt reality for finance teams: federal relief programs keep the same federal scheduling assumptions, even when the policy intent was economic stabilization. Expect more repayment pain and more cautious counsel memos as operators reconcile what they filed with what courts will tolerate. (Bloomberg Tax)

🔫 Cato Brief Targets Gun Ban For Cannabis Users

Cato and the Reason Foundation filed an amicus brief in United States v. Hemani urging the Supreme Court to strike down the federal firearm prohibition for unlawful users of controlled substances as applied to marijuana users. The brief presses a problem that keeps widening: people who follow state cannabis law face felony exposure tied to federal forms, background checks, and selective enforcement. This is a collision with institutions that rarely compromise, especially ATF compliance culture and statutes written for a different era. Even a narrow ruling would leave Congress and regulators room to rewrite the practical rules of the road. Consumers hold the risk while the law catches up to what millions already consider normal behavior. (Cato Institute)

🗳️ Maine Adult Use Repeal Effort Misses The Ballot Deadline

A citizen petition that aimed to shut down Maine's adult-use market and tighten oversight of the medical program will not appear on the November ballot because organizers missed the signature submission deadline. That buys the industry a year of operational certainty, which matters because referendum risk freezes capital and encourages short-term behavior even when a market is otherwise functioning. The campaign can regroup for a later cycle, so this is a delay, and policymakers should treat it as a warning shot about how quickly medical oversight debates get folded into prohibition politics. Maine also saw complaints about how the petition was pitched to voters, a credibility problem that tends to poison the well for any legitimate testing and safety reforms the state may still need. The near-term consequence is a calmer planning horizon for operators and a longer runway for the state to address medical guardrails without handing prohibition advocates a clean narrative. (Portland Press Herald)

🤠 Oklahoma Businesses Warn Repeal Talk Risks A Black Market Rebound

Oklahoma Governor Kevin Stitt is renewing his push to end the state's medical marijuana program, calling it a public safety problem tied to criminal activity and arguing the system is beyond repair. A processor interviewed in Oklahoma City acknowledged bad actors and still warned that abolition would cost jobs and push demand back into unregulated channels. The medical authority is sticking to its statutory role, which highlights the tension between political rhetoric and what an agency can legally execute. If the legislature pursues a referendum path, the state shifts from cleanup mechanics to an existential vote about whether the market should exist at all. In the meantime, licensed businesses plan payroll and leases under a cloud of uncertainty that was created in politics, not compliance. (KOCO)

🧴 Washington Still Has Not Built A Real CBD Rulebook

Federal signals on CBD keep pointing in opposite directions, with Congress floating a bill to protect the broader non-intoxicating market while policy chatter drifts toward Medicare reimbursement concepts. Medicare coverage assumes defined dosing, consistent formulation, enforceable manufacturing controls, and clear safety thresholds. The federal system has not built that foundation for hemp-derived CBD. FDA continues to say CBD cannot be sold as a dietary supplement or added to food, and it has not offered a practical alternative pathway at national scale. The result is a large consumer market governed by ambiguity, then squeezed further by looming federal THC caps that could force costly remediation and shrink lawful supply. When Washington keeps CBD in a gray zone, the market fills the gap with uneven standards and operates under permanent planning risk. (HempToday)

🧩 New Jersey CRC Seat Goes To An Advocate With Deep Roots

New Jersey Assembly Speaker Craig Coughlin is naming Jacqueline Ferraro, co-founder of the Cannabis Advisory Group, to the Cannabis Regulatory Commission in the seat the speaker controls. These appointments look procedural until you remember how much discretion a commission actually holds, from enforcement temperature to how quickly guidance gets issued when the market is confused. Ferraro brings advocacy credentials and relationships that can help the agency communicate and correct course without defaulting to punitive posture. The first practical test is whether applicants and licensees feel decisions getting tighter and more predictable. Personnel choices shape market behavior long before any new statute arrives. (POLITICO Pro)

🏥 Virginia Hospital Medical Cannabis Bill Clears Senate Hurdle

Virginia senators advanced a bill that would allow qualifying patients to access medical cannabis in hospitals once marijuana is federally rescheduled. The trigger matters because hospitals sit inside federal reimbursement, accreditation, and risk management systems that have treated cannabis as radioactive even where state law is clear. The bill forces the operational question that actually decides access: who holds the product, who administers it, and what liability looks like when something goes wrong. Hospital counsel will want narrow protocols and tight role definitions before any staff touches anything. Inpatient access becomes real when a hospital can adopt a policy it is willing to defend, not when a legislature declares permission in theory. (Marijuana Moment)

🤠 Texas Fee Shock Threatens Hemp THC Access

Texas health officials proposed a major licensing fee hike for consumable hemp THC sellers, moving retail from $150 to $20,000 per location and manufacturers from $250 to $25,000 per facility. The state is framing it as an enforcement and safety funding play, paired with tighter testing, recall rules, and total THC measurement. The market effect reads like consolidation by spreadsheet, since smaller operators cannot absorb fees at that scale and demand does not disappear when storefronts close. When regulated access gets squeezed, consumers migrate to slapdash channels that skip testing and age controls, which leaves the state with less visibility and more risk. The policy choice is whether Texas wants a disciplined, age-gated lane that can survive, or a fee structure that prices it out and lets the black market backfill. (Reporting Texas)

⚖️ Cannabis Matures And The Lawsuits Follow

As capital tightens and early market optimism gets stress tested, cannabis businesses are seeing more shareholder disputes, broken deals, and commercial litigation that looks familiar to any general counsel. The pattern is predictable: rushed contracts, unclear governance, and financing terms written for growth turn into courtroom fights when growth stalls. Courts treat these cases as ordinary business disputes, which means judges enforce the paper that exists rather than the intent people claim they had. Compliance complexity makes discovery messy and expensive, so litigation becomes its own tax on already fragile balance sheets. Weak documentation and misaligned incentives stop being a headache and start becoming a solvency event. (Law.com, Corporate Counsel)

💸 Humboldt Growers Get Stiffed And The State Shrugs

A Humboldt County distributor is accused of leaving growers and brands unpaid for months, with one family farm documenting more than $70,000 owed after payments stopped in late summer. The story reads like a private business dispute until you remember the state built a regulated supply chain that still struggles to police basic commercial integrity inside it. California's regulator is drawing a bright line between licensing and debt collection, which leaves smaller operators with expensive lawsuits as their main tool while they keep making payroll and paying taxes. The predictable outcome is more off-book behavior and more reliance on personal trust, because the legal market keeps forcing people to eat losses that would be unacceptable in any other regulated commodity. When distributors fail to pay, the damage radiates backward to cultivation and forward to brands, and the only thing that moves fast is the resentment. (Redheaded Blackbelt)

🏗️ Ohio Cultivation Facility Sale Signals A REIT Reset

A Chicago-based cannabis real estate REIT sold a former Ayr cultivation facility in Parma, Ohio for $28.5 million, and Ayr will keep operating the site under the new owner. Deals like this show up when operators need cash now and can live with rent later, especially after restructurings that tighten every other financing option. The buyer's ties to specialized capital signal that investors still want the rent stream even when operators are underwater. Ohio adult-use growth gives the asset a real revenue backdrop, yet the balance sheet math still pushes operators to monetize walls and equipment instead of finding cheaper debt. Control of real estate drifts away from operators, and fixed monthly costs become the governor on how much risk they can take. (MJBizDaily)

🏙️ Bronx Cannabis Hub Pitches A Scalable Equity Model

Bronx leaders are urging Albany to reinvest cannabis tax revenue into community-run support models that turn eligibility into actual storefronts. They point to the Bronx Cannabis Hub's mix of legal help, business counseling, licensing support, and mentorship as a way to get justice-involved entrepreneurs through the choke points that stall most equity programs. The argument is also about market structure, because delays, high startup costs, and scarce compliant real estate reward operators with cheaper capital and deeper benches. New York's equity promise becomes durable when the state funds the infrastructure that helps small operators survive the long middle of licensing and buildout. When equity programs fail in practice, the political damage lands on government credibility, not on the investors waiting in the wings. (Crain’s New York Business)

🥤 Restaurants Start Treating THC Drinks Like A Beverage Category

Restaurants and bars are starting to test hemp-derived THC drinks as alcohol consumption softens and consumers look for alternatives that still feel social. The operational reality is messy: most sales still live in convenience, grocery, and direct-to-consumer channels, while hospitality wants reliable supply, consistent dosing, and products that will still exist next quarter. Policy remains the hard constraint, with federal hemp uncertainty and state rules splitting on dose limits and where products can be sold. Some operators will experiment at the edges, and most will wait for stability before they build a serious beverage program. This category grows fastest when it can behave like a boring beverage business, not a policy wager. (Nation’s Restaurant News)

👠 Patricia Field Brings THC Drinks Into Fashion Week

Patricia Field is using New York Fashion Week as the stage for a capsule collaboration tied to Black Market, a hemp-derived delta-9 THC beverage brand. The project treats THC as a lifestyle ingredient that belongs in nightlife, art, and design, with designers reworking bottles and building an event around experience rather than dispensary culture. That visibility matters because New York's intoxicating hemp lane sits under legislative pressure, and high-profile activations give regulators a reason to prove they're watching the channel. Brands are also selling a social substitution story, positioning THC as an alternative ritual in rooms where alcohol has always owned the script. Culture moves fast, and compliance follows it into the spotlight. (High Times)

🥤 Hemp Drink Bans Risk A Consumer Backlash

An op-ed argues hemp-derived THC beverages have become a first cannabis touchpoint for many adults because they sit in normal retail and feel familiar. Broad bans do more than squeeze brands, they harden a public sense that legalization remains unstable and arbitrary. The smarter regulatory fight is lane discipline: age-gated, low-dose products with auditable labeling and testing controls, separated from synthetics and slapdash channels that hide the ball. When states sweep the whole category into a ban, demand shifts into weaker outlets and enforcement gets harder, not easier. When people lose a product they already see as normal, trust in the rules erodes fast. (Marijuana Moment)

🧠 Cannabis Use Tied To Brain Volume In Older Adults Study

Researchers using UK Biobank data report an association between lifetime cannabis use and larger volume in several brain regions plus better cognitive performance among adults ages 40 to 77. The dataset cannot tell you what people used, how potent it was, or how today’s products map onto older exposure patterns, so it is a limited lens by design. The policy relevance is how quickly findings like this get pulled into marketing and public debates that want clean answers. Clinicians and regulators still have to separate occasional use from heavy daily use, and separate older adult outcomes from adolescent risk narratives. Evidence travels faster than practical guidance, especially when the topic is already politicized. (CU Anschutz Medical Campus)

🌹 A Cannabis Plant Won A Major European Garden Show Prize

A cannabis entry won the public vote at IPM Essen, a mainstream European horticulture trade show that usually celebrates ornamentals and food crops. That venue matters because normalization often shows up first when industry gatekeepers treat cannabis like any other commercial breeding product. Europe still carries real regulatory friction around how cannabis is sold, who can profit, and what claims can be made. Cultural comfort keeps widening, and policy tends to follow with a delay. Acceptance is rising faster than the rules that govern the business behind it. (High Times)